These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 26874214)
1. Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant. Jelcic I; Jelcic I; Kempf C; Largey F; Planas R; Schippling S; Budka H; Sospedra M; Martin R Ann Neurol; 2016 Mar; 79(3):404-18. PubMed ID: 26874214 [TBL] [Abstract][Full Text] [Related]
2. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874 [TBL] [Abstract][Full Text] [Related]
4. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701 [TBL] [Abstract][Full Text] [Related]
5. JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Schippling S; Kempf C; Büchele F; Jelcic I; Bozinov O; Bont A; Linnebank M; Sospedra M; Weller M; Budka H; Martin R Ann Neurol; 2013 Oct; 74(4):622-6. PubMed ID: 23868420 [TBL] [Abstract][Full Text] [Related]
6. TCR bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD4+ T cells during viral infection. Yousef S; Planas R; Chakroun K; Hoffmeister-Ullerich S; Binder TM; Eiermann TH; Martin R; Sospedra M J Immunol; 2012 Oct; 189(7):3618-30. PubMed ID: 22942431 [TBL] [Abstract][Full Text] [Related]
7. Immunology of progressive multifocal leukoencephalopathy. Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538 [TBL] [Abstract][Full Text] [Related]
8. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217 [TBL] [Abstract][Full Text] [Related]
9. JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Agnihotri SP; Dang X; Carter JL; Fife TD; Bord E; Batson S; Koralnik IJ Neurology; 2014 Aug; 83(8):727-32. PubMed ID: 25037207 [TBL] [Abstract][Full Text] [Related]
10. Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus. O'Neill FJ; Greenlee JE; Dörries K; Clawson SA; Carney H J Neurovirol; 2003 Oct; 9(5):567-76. PubMed ID: 13129771 [TBL] [Abstract][Full Text] [Related]
11. Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy. Perkins MR; Ryschkewitsch C; Liebner JC; Monaco MC; Himelfarb D; Ireland S; Roque A; Edward HL; Jensen PN; Remington G; Abraham T; Abraham J; Greenberg B; Kaufman C; LaGanke C; Monson NL; Xu X; Frohman E; Major EO; Douek DC PLoS Pathog; 2012; 8(11):e1003014. PubMed ID: 23144619 [TBL] [Abstract][Full Text] [Related]
12. Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation. Iannetta M; Zingaropoli MA; Bellizzi A; Morreale M; Pontecorvo S; D'Abramo A; Oliva A; Anzivino E; Lo Menzo S; D'Agostino C; Mastroianni CM; Millefiorini E; Pietropaolo V; Francia A; Vullo V; Ciardi MR PLoS One; 2016; 11(8):e0160277. PubMed ID: 27486658 [TBL] [Abstract][Full Text] [Related]
13. In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection. Martin-Blondel G; Bauer J; Cuvinciuc V; Uro-Coste E; Debard A; Massip P; Delisle MB; Lassmann H; Marchou B; Mars LT; Liblau RS Neurology; 2013 Sep; 81(11):964-70. PubMed ID: 23935178 [TBL] [Abstract][Full Text] [Related]
14. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. Wüthrich C; Batson S; Koralnik IJ J Neuropathol Exp Neurol; 2015 Aug; 74(8):791-803. PubMed ID: 26115192 [TBL] [Abstract][Full Text] [Related]
15. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394 [TBL] [Abstract][Full Text] [Related]
16. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. Koralnik IJ; Du Pasquier RA; Letvin NL J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876 [TBL] [Abstract][Full Text] [Related]
17. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa. Glass AJ; Venter M J Med Virol; 2009 Nov; 81(11):1929-37. PubMed ID: 19774679 [TBL] [Abstract][Full Text] [Related]
18. The human JC polyomavirus (JCPyV): virological background and clinical implications. Hirsch HH; Kardas P; Kranz D; Leboeuf C APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977 [TBL] [Abstract][Full Text] [Related]